NEW YORK (GenomeWeb News) – DDC Medical has signed a licensing agreement with the National Institute of Standards and Technology to commercialize mouse cell line authentication using STR DNA technology, the firm announced today.

The DDC mouse cell line authentication test uses STR DNA analysis for mouse DNA characterization, and the loci that are selected produce "stable robust results based on a tetranucleotide repeat, similar to the types of loci examined for human cell line authentication," the company said.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Researchers hope to tease out the signature effects that different carcinogens leave on the genome to determine their contributions to disease, Mosaic reports.

The Wall Street Journal looks into the cost of new gene therapies.

An Imperial College London-led team reports that it was able to use a gene drive to control a population of lab mosquitos.

In PNAS this week: genomic effects of silver fox domestication, limited effect of mitochondrial mutations on aging in fruit flies, and more.